NCT07227311
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07227311
Title A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP | DEU

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Los Alamitos California 90720 United States Details
GSK Investigational Site RECRUITING Torrance California 90505 United States Details
GSK Investigational Site RECRUITING Whittier California 90602 United States Details
GSK Investigational Site RECRUITING Fort Myers Florida 33912 United States Details
GSK Investigational Site RECRUITING Macon Georgia 31210 United States Details
GSK Investigational Site RECRUITING Bethesda Maryland 20817 United States Details
GSK Investigational Site RECRUITING Bridgeton Missouri 63044 United States Details
GSK Investigational Site RECRUITING Springfield Missouri 65807 United States Details
GSK Investigational Site RECRUITING Farmington New Mexico 87401 United States Details
GSK Investigational Site RECRUITING Paris 75012 France Details
GSK Investigational Site RECRUITING Paris 75475 France Details
GSK Investigational Site RECRUITING Koblenz 56068 Germany Details
GSK Investigational Site RECRUITING Aichi 467-8602 Japan Details
GSK Investigational Site RECRUITING Chiba 277-8567 Japan Details
GSK Investigational Site RECRUITING Ehime 790-8524 Japan Details
GSK Investigational Site RECRUITING Fukushima 960-1295 Japan Details
GSK Investigational Site RECRUITING Gunma 371-8511 Japan Details
GSK Investigational Site RECRUITING Ishikawa 920-8641 Japan Details
GSK Investigational Site RECRUITING Numakunai 028-3695 Japan Details
GSK Investigational Site RECRUITING Okayama 701-1192 Japan Details
GSK Investigational Site RECRUITING Osaka 590-0197 Japan Details
GSK Investigational Site RECRUITING Tokyo 105-8471 Japan Details
GSK Investigational Site RECRUITING Amersfoort 3813 TZ Netherlands Details
GSK Investigational Site RECRUITING Jerez de la Frontera Andalusia 11407 Spain Details
GSK Investigational Site RECRUITING Gijón 33394 Spain Details
GSK Investigational Site RECRUITING Madrid Spain Details
GSK Investigational Site RECRUITING Salamanca Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field